DJIA 17,799.10 -10.96 -0.06%
NASDAQ 4,743.44 30.47 0.65%
S&P 500 2,066.56 3.06 0.15%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

Stop Worrying About Ebola: This is a Much More Pressing Concern

Ebola may be garnering all of the headlines, but this infectious disease has been a contributing factor to the eighth leading cause of death in the U.S.

Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen

Vanguard FTSE Developed Markets ETF Experiences Big Inflow

J.P. Morgan’s 5 Top International Stock Picks

Novartis Presents Data on Heart Failure Candidate LCZ696 - Analyst Blog

Sanofi's Lemtrada Gets U.S. Approval, Carries Boxed Warning - Analyst Blog

Novartis Int'l Reports Nine New Analyses Show Co.'s LCZ696 Could Avert Course of Heart Failure for P

Novartis Int'l Reports Nine New Analyses Show Co.'s LCZ696 Could Avert Course of Heart Failure for Patients

Incyte Building Blockbuster Drug One Disease At A Time

Jim Cramer Answers Twitter (TWTR) Questions on Gold, Gilead and More

How to Pick Stocks in the Wake of the Republican Election Victory

See More Articles...